BIOREM Inc.
BIRMF
$2.15
-$0.07-3.15%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.90M | 12.15M | 8.17M | 6.82M | 3.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.90M | 12.15M | 8.17M | 6.82M | 3.30M |
| Cost of Revenue | 3.90M | 7.89M | 5.87M | 4.97M | 2.52M |
| Gross Profit | 1.00M | 4.26M | 2.30M | 1.84M | 773.30K |
| SG&A Expenses | 861.00K | 1.52M | 1.10M | 1.07M | 712.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 0.00 | -- | -- |
| Total Operating Expenses | 4.77M | 9.39M | 7.01M | 6.05M | 3.25M |
| Operating Income | 132.90K | 2.76M | 1.16M | 764.50K | 50.90K |
| Income Before Tax | 195.70K | 2.65M | 1.14M | 732.40K | 35.20K |
| Income Tax Expenses | 50.90K | 582.90K | 303.00K | 194.10K | 9.30K |
| Earnings from Continuing Operations | 144.80K | 2.06M | 840.40K | 538.30K | 25.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 144.80K | 2.06M | 840.40K | 538.30K | 25.90K |
| EBIT | 132.90K | 2.76M | 1.16M | 764.50K | 50.90K |
| EBITDA | 198.40K | 2.82M | 1.25M | 843.50K | 144.60K |
| EPS Basic | 0.01 | 0.14 | 0.05 | 0.03 | 0.00 |
| Normalized Basic EPS | 0.01 | 0.11 | 0.04 | 0.03 | 0.00 |
| EPS Diluted | 0.01 | 0.12 | 0.05 | 0.03 | 0.00 |
| Normalized Diluted EPS | 0.01 | 0.10 | 0.04 | 0.02 | 0.00 |
| Average Basic Shares Outstanding | 16.13M | 14.87M | 16.01M | 16.03M | 16.14M |
| Average Diluted Shares Outstanding | 18.30M | 16.73M | 18.63M | 18.61M | 18.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |